Skip to content
No results
  • Home
  • First year subjects
    • Anatomy and physiology
    • Pharmaceutics
    • Medicinal Biochemistry
    • Pharmaceutical Inorganic Chemistry
    • Pharmaceutical Organic Chemistry
    • Remedial Mathematics
  • Second year subjects
    • Pathophysiology
    • Pharmaceutical Microbiology
    • Pharmacognosy and Phytopharmaceuticals
    • Pharmacology-1
    • Community Pharmacy
    • Pharmacotherapeutics-1
  • Third year subjects
    • Pharmacology-2
    • Pharmaceutical Analysis
    • Pharmacotherapeutics-2
    • Pharmaceutical Jurisprudence
    • Medicinal Chemistry
    • Pharmaceutical Formulations
  • Fourth year subjects
    • Pharmacotherapeutics-3
    • Hospital Pharmacy
    • Clinical Pharmacy
    • Biostatistics and Research Methodology
    • Biopharmaceutics and Pharmacokinetics
    • Clinical Toxicology
  • Fifth year subjects
    • Clinical research
    • Pharmacoepidemiology
    • TDM
  • Contact Us
PHARMD GURU
  • Home
  • First year subjects
    • Anatomy and physiology
    • Pharmaceutics
    • Medicinal Biochemistry
    • Pharmaceutical Inorganic Chemistry
    • Pharmaceutical Organic Chemistry
    • Remedial Mathematics
  • Second year subjects
    • Pathophysiology
    • Pharmaceutical Microbiology
    • Pharmacognosy and Phytopharmaceuticals
    • Pharmacology-1
    • Community Pharmacy
    • Pharmacotherapeutics-1
  • Third year subjects
    • Pharmacology-2
    • Pharmaceutical Analysis
    • Pharmacotherapeutics-2
    • Pharmaceutical Jurisprudence
    • Medicinal Chemistry
    • Pharmaceutical Formulations
  • Fourth year subjects
    • Pharmacotherapeutics-3
    • Hospital Pharmacy
    • Clinical Pharmacy
    • Biostatistics and Research Methodology
    • Biopharmaceutics and Pharmacokinetics
    • Clinical Toxicology
  • Fifth year subjects
    • Clinical research
    • Pharmacoepidemiology
    • TDM
  • Contact Us
PHARMD GURU
BIOAVAILABILITY AND BIOEQUIVALENCE
  • Biopharmaceutics and Pharmacokinetics

12. BIOAVAILABILITY AND BIOEQUIVALENCE

Bioavailability and bioequivalence are two core concepts of biopharmaceutics and regulatory science. They help determine how much of a drug reaches systemic circulation and whether two drug products behave the…

NON COMPARTMENTAL PHARMACOKINETICS
  • Biopharmaceutics and Pharmacokinetics

11. NON-COMPARTMENTAL PHARMACOKINETICS

Non-compartmental pharmacokinetics (NCA) is a simple and practical method used to describe how a drug moves through the body without assuming any specific compartment model. Instead of dividing the body…

NON LINEAR PHARMACOKINETICS
  • Biopharmaceutics and Pharmacokinetics

10. NON-LINEAR PHARMACOKINETICS

Most drugs follow linear pharmacokinetics, where the drug concentration increases in direct proportion to the dose. However, some drugs behave differently and show non-linear pharmacokinetics. In this case, small changes…

MULTIPLE DOSAGE REGIMENS
  • Biopharmaceutics and Pharmacokinetics

9. MULTIPLE DOSAGE REGIMENS

Most medications are not given as a single dose. They are administered repeatedly at fixed intervals to maintain consistent therapeutic levels. This is known as a multiple dosage regimen. Understanding…

MULTICOMPARTMENT MODELS
  • Biopharmaceutics and Pharmacokinetics

8. MULTI-COMPARTMENT MODELS

Some drugs do not distribute instantly throughout the body. Instead, they move into different tissues at different speeds. For such drugs, the one-compartment model is not enough. This is where…

ONE COMPARTMENT OPEN MODEL FOR INTRAVENOUS INFUSION
  • Biopharmaceutics and Pharmacokinetics

7. ONE-COMPARTMENT OPEN MODEL FOR INTRAVENOUS INFUSION

In an intravenous infusion, a drug is delivered slowly and continuously into the bloodstream at a controlled rate. Unlike IV bolus dosing, where the entire dose enters the body instantly,…

ONE COMPARTMENT OPEN MODEL INTRAVENOUS INJECTION
  • Biopharmaceutics and Pharmacokinetics

6. ONE-COMPARTMENT OPEN MODEL INTRAVENOUS INJECTION

Introduction The one compartment open model is one of the simplest and most commonly used pharmacokinetic models. It is especially useful for understanding how a drug behaves after it is…

1 2
Next

Trending now

RNA PROCESSING, PROTEIN SYNTHESIS, AND GENE REGULATION
25. RNA PROCESSING, PROTEIN SYNTHESIS, AND GENE REGULATION
NOMOGRAMS AND TABULATIONS IN DESIGNING DOSAGE REGIMEN
2. NOMOGRAMS AND TABULATIONS IN DESIGNING DOSAGE REGIMEN
CONVERSION FROM INTRAVENOUS TO ORAL DOSING
3. CONVERSION FROM INTRAVENOUS TO ORAL DOSING
DETERMINATION OF DOSE AND DOSING INTERVALS
4. DETERMINATION OF DOSE AND DOSING INTERVALS
  • About Us
  • TERMS & CONDITIONS
  • PRIVACY POLICY
  • Disclaimer

Copyright © 2025 PHARMD GURU